DOCSLIB.ORG

Histotoxic Clostridial Infections MASAHIRO NAGAHAMA,1 MASAYA TAKEHARA,1 and JULIAN I

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Histotoxic Clostridial Infections MASAHIRO NAGAHAMA,1 MASAYA TAKEHARA,1 and JULIAN I Histotoxic Clostridial Infections MASAHIRO NAGAHAMA,1 MASAYA TAKEHARA,1 and JULIAN I. ROOD2 1Department of Microbiology, Faculty of Pharmaceutical Sciences, Tokushima Bunri University, Yamashiro-cho, Tokushima 770-8514, Japan; 2Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Microbiology, Monash University, Clayton, Victoria 3800, Australia ABSTRACT The pathogenesis of clostridial myonecrosis or Although the histotoxic clostridia cause severe, gas gangrene involves an interruption to the blood supply to rapidly developing infections, these potent toxigenic the infected tissues, often via a traumatic wound, anaerobic bacteria still must be regarded as opportunistic patho- growth of the infecting clostridial cells, the production of gens. All of these infections require predisposing extracellular toxins, and toxin-mediated cell and tissue damage. This review focuses on host-pathogen interactions conditions to cause disease, often a traumatic wound in Clostridium perfringens-mediated and Clostridium that enables the entry of spores from the soil or gastro- septicum-mediated myonecrosis. The major toxins involved intestinal tract to gain access to ischemic internal organs are C. perfringens α-toxin, which has phospholipase C and or soft tissues of the body. Alternatively, in nontrau- sphingomyelinase activity, and C. septicum α-toxin, matic myonecrosis caused by C. septicum, gastrointes- β a -pore-forming toxin that belongs to the aerolysin family. tinal malignancy is commonly associated with the onset ff Although these toxins are cytotoxic, their e ects on host of disease, with tumor development leading to ulceration cells are quite complex, with a range of intracellular cell signaling pathways induced by their action on host cell membranes. and necrosis of the gastrointestinal mucosa and entry of the gastrointestinal microbiota into the circulation and subsequent infection at distal sites (3, 4). Clostridial GENERAL CHARACTERISTICS OF necrotizing soft tissue infections, especially those caused HISTOTOXIC CLOSTRIDIAL INFECTIONS by C. perfringens, Clostridium sordellii, and Clostri- Many pathogenic clostridial species cause potentially dium novyi, also have resulted from the subcutaneous – fatal soft tissue infections in humans and animals be- injection of contaminated black tar heroin (5 7). cause of their ability to produce extracellular protein toxins (1, 2). The ability of these pathogens to produce Received: 19 March 2018, Accepted: 23 March 2018, spores that are resistant to environmental stress is an Published: 26 July 2019 Editors: Vincent A. Fischetti, The Rockefeller University, New York, important factor in the epidemiology of these diseases. NY; Richard P. Novick, Skirball Institute for Molecular Medicine, Disease pathogenesis involves the growth of the clos- NYU Medical Center, New York, NY; Joseph J. Ferretti, Department tridial pathogen in the tissues and extensive tissue de- of Microbiology & Immunology, University of Oklahoma Health Science Center, Oklahoma City, OK; Daniel A. Portnoy, Department struction, which is the result of the action of extracellular of Molecular and Cellular Microbiology, University of California, toxins. Typical histotoxic clostridial diseases include Berkeley, Berkeley, CA; Miriam Braunstein, Department of Microbiology and Immunology, University of North Carolina-Chapel human gas gangrene or myonecrosis and blackleg in Hill, Chapel Hill, NC, and Julian I. Rood, Infection and Immunity cattle. Although there are several clostridial species that Program, Monash Biomedicine Discovery Institute, Monash are responsible for these syndromes (Table 1), this University, Melbourne, Australia review will focus on histotoxic infections caused by Citation: Nagahama M, Takehara M, Rood JI. 2019. Histotoxic clostridial infections. Microbiol Spectrum 6(4):GPP3-0024-2018. Clostridium perfringens and Clostridium septicum, doi:10.1128/microbiolspec.GPP3-0024-2018. primarily because these are the species that have been Correspondence: Masahiro Nagahama, [email protected] the subject of the most extensive molecular and func- -u.ac.jp or Julian I. Rood, [email protected] tional studies. © 2019 American Society for Microbiology. All rights reserved. ASMscience.org/MicrobiolSpectrum 1 Downloaded from www.asmscience.org by IP: 130.194.145.38 On: Fri, 06 Sep 2019 02:16:21 Nagahama et al. TABLE 1 Histotoxic clostridial infections Syndromea Causative agent Host Major toxinsb References Traumatic gas gangrene C. perfringens type A Humans α-toxin 12, 17 Perfringolysin O (θ-toxin) Traumatic gas gangrene C. novyi Humans α-toxin 151 C. septicum α-toxin 129 C. histolyticum Lethal factor 152 C. sordellii Lethal toxin (TcsL) 153 Hemorrhagic toxin (TcsH) Nontraumatic gas gangrene C. septicum Humans α-toxin 3, 4 C. fallax Humans and animals Not known 154 Necrotizing pancreatitis C. perfringens type A Humans α-toxin 155 Clostridial myonecrosis C. perfringens types A, B, C, and D Sheep, cattle, and other animals α-toxin 29 β-toxin ε-toxin Blackleg C. chauvoei Cattle, sheep, and other ruminants Cytolysin A (CctA) 156 aThe terms “gas gangrene” and “clostridial myonecrosis” are used interchangeably in this review. bNote that the different α-toxins referred to in this column are not necessarily structurally or functionally related. PATHOGENESIS OF CLOSTRIDIAL coli, and therefore devoid of any other C. perfringens MYONECROSIS CAUSED BY toxins, showed that the C-terminal domain of α-toxin C. PERFRINGENS AND C. SEPTICUM was immunoprotective (14). Second, mutation of the As previously described (8), the pathogenesis of these α-toxin structural gene (plc or cpa) abrogated the ability infections involves three distinct stages, irrespective of of the bacterium to cause clostridial myonecrosis in a whether the source of infection involves a traumatic murine model. Virulence was restored by complemen- wound. Stage 1 involves an interruption to the blood tation in trans with a recombinant plasmid containing supply such that the redox potential in the tissues drops the wild-type plc gene (15), thereby fulfilling molecular to a level that facilitates spore germination and/or the Koch’s postulates and providing proof of the essential growth of the infecting clostridial cells. Stage 2 involves role of this toxin in disease. bacterial growth and establishment of the conditions for The other major toxin produced by C. perfringens toxin production. In C. perfringens, regulation of toxin type A is perfringolysin O, or θ-toxin, a pore-forming production primarily utilizes the VirSR two-component toxin that is a member of the cholesterol-dependent cy- signal transduction system (9) and an accessory growth tolysin family (16, 17). Although mutation of the per- regulator-like quorum sensing system (10, 11), as well fringolysin O structural gene, pfoA, did not eliminate as other regulatory networks. Stage 3 encompasses the the ability to cause disease (18, 19) subsequent studies toxin-mediated cell and tissue damage that leads to ne- of plcpfoA double mutants (20) provided evidence that crosis, systemic toxicity, and clinical disease (8). perfringolysin O has a synergistic effect with α-toxin on C. perfringens type A is the major cause of traumatic disease pathogenesis (20, 21). gas gangrene, although other histotoxic clostridia may Recent studies have involved the concurrent analy- also be responsible for this sporadic, but fulminant sis of the transcriptomes of both the host and C. per- and often fatal, disease (Table 1)(1). The major toxin fringens in a murine myonecrosis infection (22). The produced by gas gangrene strains of C. perfringens is results showed that many host genes involved in the α-toxin, a zinc metallophospholipase that has both innate immune response to infection were upregulated phospholipase C and sphingomyelinase activity (12). in C. perfringens-infected muscle tissues. In the C. per- α-Toxin was the first bacterial toxin to be shown to have fringens cells, upregulated genes included those en- enzymatic activity (13). Two independent studies using coding potential adhesins and proteins associated with different experimental approaches have shown that the cell envelope. α-toxin is essential for C. perfringens-mediated myo- C. septicum is the major causative agent of nontrau- necrosis. First, immunization studies in mice using re- matic gas gangrene, often associated with a gastro- combinant α-toxin variants purified from Escherichia intestinal malignancy (4). The major toxin produced 2 ASMscience.org/MicrobiolSpectrum Downloaded from www.asmscience.org by IP: 130.194.145.38 On: Fri, 06 Sep 2019 02:16:21 Histotoxic Clostridial Infections by C. septicum is also called α-toxin, but it is not related to C. perfringens α-toxin. C. septicum α-toxin is an aerolysin-like pore-forming toxin that is secreted as an inactive prototoxin that is cleaved near the C terminus by membrane-bound furin or furin-like proteases to form the active toxin (23). The toxin then oligomerizes on the membrane and subsequently inserts to form a membrane pore, which ultimately leads to cell lysis (24). Genetic studies have shown that α-toxin is essential for C. septicum-mediated myonecrosis in mice (25). Muta- tion of the α-toxin structural gene, csa, leads to a loss of virulence, which is restored by complementation with the wild-type csa gene. STRUCTURE AND FUNCTION OF C. PERFRINGENS α-TOXIN FIGURE 1 Structure of α-toxin. The structure of α-toxin was α obtained from the Protein Data Bank (code 1QM6) and was -Toxin
Load more

Recommended publications
  • Gas Gangrene Infection of the Eyes and Orbits
    Br J Ophthalmol: first published as 10.1136/bjo.69.2.143 on 1 February 1985. Downloaded from British Journal of Ophthalmology, 1985, 69, 143-148 Gas gangrene infection of the eyes and orbits GERARD W CROCK,' WILSON J HERIOT,' PATTABIRAMAN JANAKIRAMAN,' AND JOHN M WEINER2 From the 'Department of Ophthalmology, University ofMelbourne, and the2C H Greer Pathology Laboratory, the Royal Victorian Eye and Ear Hospital, East Melbourne, Australia SUMMARY The literature on Clostridium perfringens infections is reviewed up to 1983. An additional case is reported with bilateral clostridial infections of the eye and orbit. One eye followed the classical course of relentless panophthalmitis, amaurosis, and orbital cellulitis ending in enucleation. The second eye contained intracameral mud and gas bubbles that were removed by vitrectomy instrumentation. Subsequent removal of the toxic cataract resulted in a final aided visual acuity of 6/18, N8. This is the third report of a retained globe, and we believe the only known case where the patient was left with useful vision. Clostridium perfringens is a ubiquitous Gram- arms, chest, and abdomen. He was admitted to a positive bacillus found in soil and bowel flora. It is the general hospital, where he was examined under most common of four clostridia species identified in anaesthesia, and his injuries were attended to. copyright. cases of gas gangrene in man.' All species are obligate Ocular findings. The right cornea and anterior anaerobes and are usually saprophytic rather than chamber were intact. There was a scleral laceration pathogenic. Clostridium perfringens is a feared con- over the superonasal area of the pars plana with taminant of limb injuries and may result in death due vitreous prolapse.
    [Show full text]
  • Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis
    International Journal of Molecular Sciences Review Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis David Johane Machate 1, Priscila Silva Figueiredo 2 , Gabriela Marcelino 2 , Rita de Cássia Avellaneda Guimarães 2,*, Priscila Aiko Hiane 2 , Danielle Bogo 2, Verônica Assalin Zorgetto Pinheiro 2, Lincoln Carlos Silva de Oliveira 3 and Arnildo Pott 1 1 Graduate Program in Biotechnology and Biodiversity in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] (D.J.M.); [email protected] (A.P.) 2 Graduate Program in Health and Development in the Central-West Region of Brazil, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; pri.fi[email protected] (P.S.F.); [email protected] (G.M.); [email protected] (P.A.H.); [email protected] (D.B.); [email protected] (V.A.Z.P.) 3 Chemistry Institute, Federal University of Mato Grosso do Sul, Campo Grande 79079-900, Brazil; [email protected] * Correspondence: [email protected]; Tel.: +55-67-3345-7416 Received: 9 March 2020; Accepted: 27 March 2020; Published: 8 June 2020 Abstract: Long-term high-fat dietary intake plays a crucial role in the composition of gut microbiota in animal models and human subjects, which affect directly short-chain fatty acid (SCFA) production and host health. This review aims to highlight the interplay of fatty acid (FA) intake and gut microbiota composition and its interaction with hosts in health promotion and obesity prevention and its related metabolic dysbiosis.
    [Show full text]
  • Diagnostic Code Descriptions (ICD9)
    INFECTIONS AND PARASITIC DISEASES INTESTINAL AND INFECTIOUS DISEASES (001 – 009.3) 001 CHOLERA 001.0 DUE TO VIBRIO CHOLERAE 001.1 DUE TO VIBRIO CHOLERAE EL TOR 001.9 UNSPECIFIED 002 TYPHOID AND PARATYPHOID FEVERS 002.0 TYPHOID FEVER 002.1 PARATYPHOID FEVER 'A' 002.2 PARATYPHOID FEVER 'B' 002.3 PARATYPHOID FEVER 'C' 002.9 PARATYPHOID FEVER, UNSPECIFIED 003 OTHER SALMONELLA INFECTIONS 003.0 SALMONELLA GASTROENTERITIS 003.1 SALMONELLA SEPTICAEMIA 003.2 LOCALIZED SALMONELLA INFECTIONS 003.8 OTHER 003.9 UNSPECIFIED 004 SHIGELLOSIS 004.0 SHIGELLA DYSENTERIAE 004.1 SHIGELLA FLEXNERI 004.2 SHIGELLA BOYDII 004.3 SHIGELLA SONNEI 004.8 OTHER 004.9 UNSPECIFIED 005 OTHER FOOD POISONING (BACTERIAL) 005.0 STAPHYLOCOCCAL FOOD POISONING 005.1 BOTULISM 005.2 FOOD POISONING DUE TO CLOSTRIDIUM PERFRINGENS (CL.WELCHII) 005.3 FOOD POISONING DUE TO OTHER CLOSTRIDIA 005.4 FOOD POISONING DUE TO VIBRIO PARAHAEMOLYTICUS 005.8 OTHER BACTERIAL FOOD POISONING 005.9 FOOD POISONING, UNSPECIFIED 006 AMOEBIASIS 006.0 ACUTE AMOEBIC DYSENTERY WITHOUT MENTION OF ABSCESS 006.1 CHRONIC INTESTINAL AMOEBIASIS WITHOUT MENTION OF ABSCESS 006.2 AMOEBIC NONDYSENTERIC COLITIS 006.3 AMOEBIC LIVER ABSCESS 006.4 AMOEBIC LUNG ABSCESS 006.5 AMOEBIC BRAIN ABSCESS 006.6 AMOEBIC SKIN ULCERATION 006.8 AMOEBIC INFECTION OF OTHER SITES 006.9 AMOEBIASIS, UNSPECIFIED 007 OTHER PROTOZOAL INTESTINAL DISEASES 007.0 BALANTIDIASIS 007.1 GIARDIASIS 007.2 COCCIDIOSIS 007.3 INTESTINAL TRICHOMONIASIS 007.8 OTHER PROTOZOAL INTESTINAL DISEASES 007.9 UNSPECIFIED 008 INTESTINAL INFECTIONS DUE TO OTHER ORGANISMS
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • Early History of Infectious Disease 
    © Jones and Bartlett Publishers. NOT FOR SALE OR DISTRIBUTION CHAPTER ONE EARLY HISTORY OF INFECTIOUS 1 DISEASE Kenrad E. Nelson, Carolyn F. Williams Epidemics of infectious diseases have been documented throughout history. In ancient Greece and Egypt accounts describe epidemics of smallpox, leprosy, tuberculosis, meningococcal infections, and diphtheria.1 The morbidity and mortality of infectious diseases profoundly shaped politics, commerce, and culture. In epidemics, none were spared. Smallpox likely disfigured and killed Ramses V in 1157 BCE, although his mummy has a significant head wound as well.2 At times political upheavals exasperated the spread of disease. The Spartan wars caused massive dislocation of Greeks into Athens triggering the Athens epidemic of 430–427 BCE that killed up to one half of the population of ancient Athens.3 Thucydides’ vivid descriptions of this epidemic make clear its political and cultural impact, as well as the clinical details of the epidemic.4 Several modern epidemiologists have hypothesized on the causative agent. Langmuir et al.,5 favor a combined influenza and toxin-producing staphylococcus epidemic, while Morrens and Chu suggest Rift Valley Fever.6 A third researcher, Holladay believes the agent no longer exists.7 From the earliest times, man has sought to understand the natural forces and risk factors affecting the patterns of illness and death in society. These theories have evolved as our understanding of the natural world has advanced, sometimes slowly, sometimes, when there are profound break- throughs, with incredible speed. Remarkably, advances in knowledge and changes in theory have not always proceeded in synchrony. Although wrong theories or knowledge have hindered advances in understanding, there are also examples of great creativity when scientists have successfully pursued their theories beyond the knowledge of the time.
    [Show full text]
  • Gas Gangrene – How High Do We Amputate?
    PR03D Gas Gangrene – How High Do We Amputate? Sri Kumar SK, Savarirajo JC, Boniface Deyoi Y, Faruk Senan N, Kamaruddin F Department of Orthopaedics, Sarawak General Hospital, Jalan Hospital, 93586, Kuching, Sarawak, Malaysia INTRODUCTION underwent an AKA which is 62.5% compared Different types of skin infections exist which to 40%. are caused by different organisms and which occur at different fascial planes or anatomical Figure 1: Gas gangrene of levels of the skin. Severe skin infections lead to the foot vascular occlusion, ischaemia and eventually tissue necrosis. Gas gangrene or clostridial myonecrosis is a rapid spreading and deadly disease with a specific clinical sign of gas Figure 2: X-ray of the ankle formation which can and may lead to death if showing gas shadows not diagnosed and managed early. Early management with intravenous antibiotics as well as amputation are indicated. As such we wish to investigate what are the lifesaving emergency amputations that bring more benefit to the patient than none. DISCUSSION All the patients that were admitted at our centre MATERIALS AND METHODS presented in sepsis or severe sepsis. Other This study is based on nineteen (19) patients clinical signs were darkish discoloration of the who were admitted at our centre for treatment affected lower limb, poor circulation, reduced due to gas gangrene of the lower limbs during sensation, purulent discharge and crepitus upon the period from 2015 to 2016 and were palpation which indicates gaseous formation reviewed retrospectively. beneath the skin. Clostridium perfringens which is the main organism in gas gangrene is RESULTS: usually present in decaying matter.
    [Show full text]
  • Multiorgan Fatal Gas Gangrene in the Setting of Clostridium Septicum Bacteremia: a Case Report
    7 Case Report Page 1 of 7 Multiorgan fatal gas gangrene in the setting of clostridium septicum bacteremia: a case report Omar Kousa, Amr Essa, Bashar Ramadan, Ahmed Aly, Dana Awad, Xing Zhao, Paul Millner Creighton University Medical Center Bergan Mercy, Omaha, NE, USA Correspondence to: Amr Essa. Chief Resident, Creighton University School of Medicine, Internal Medicine Department, 7710 Mercy Road, Suite 301, Omaha, NE 68124, USA. Email: [email protected]. Abstract: Gas gangrene can be traumatic or spontaneous, and most cases of spontaneous gas gangrene are caused by clostridium septicum. Clostridium septicum gas gangrene is a life-threatening disease with a high mortality of 80% in the literature, which demands a prompt diagnosis and management. We report a case of 86-year-old man with a history of myelodysplastic syndrome and diabetes mellitus who presented with non-specific symptoms that rapidly deteriorated to shock. Imaging showed extensive gas gangrene involving multiple organs and tissues. Despite aggressive supportive treatment, the patient’s condition deteriorated rapidly and passed away within 18 hours of the onset of his initial symptoms. His blood culture grew clostridium septicum. Postmortem autopsy confirmed the findings noted on imaging including, multiorgan gas gangrene, as well as identified a benign colonic ulcer that was likely the source of the infection. Our case represented the first reported human case of multiorgan C. septicum gas gangrene. It highlights the clinical, radiological, and pathological features along with the fatal and rapid deteriorating nature of such a condition. Keywords: Clostridium infection; gas gangrene; clostridium septicum; case report Received: 04 December 2019; Accepted: 26 December 2019; Published: 10 April 2020.
    [Show full text]
  • Methods in Infectious Disease Epidemiology
    1 P A R T Methods in Infectious Disease Epidemiology 1 95337_CH01_001–018.indd 1 2/1/13 11:56 PM 95337_CH01_001–018.indd 2 2/1/13 11:56 PM CHAPTER 1 Early History of Infectious Disease: Epidemiology and Control of Infectious Diseases Kenrad E. Nelson and Carolyn Masters Williams INTRODUCTION wrong theories or knowledge has hindered advances in understanding, one can also cite examples of Epidemics of infectious diseases have been docu- great creativity when scientists have successfully mented throughout history. In ancient Greece and pursued their theories beyond the knowledge of Egypt, accounts describe epidemics of smallpox, the time. leprosy, tuberculosis, meningococcal infections, and diphtheria. 1 The morbidity and mortality of in- fectious diseases profoundly shaped politics, com- THE ERA OF PLAGUES merce, and culture. In epidemics, no one was spared. Smallpox likely disfigured and killed Ramses V in The sheer magnitude and mortality of early epidemics 1157 BCE, although his mummy has a significant are difficult to imagine. Medicine and religion both head wound as well. 2 At times, political upheavals strove to console the sick and dying. However, before exacerbated the spread of disease. The Spartan wars advances in the underlying science of health, medi- caused massive dislocation of Greeks into Athens, cine lacked effective tools, and religious explana tions triggering the epidemic of 430–427 BCE that killed for disease dominated. As early communities con- up to half of the population of ancient Athens. 3 solidated people more closely, severe epidemics of Thucydides’ vivid descriptions of this epidemic make plague, smallpox, and syphilis occurred.
    [Show full text]
  • Circulatory and Lymphatic System Infections 1105
    Chapter 25 | Circulatory and Lymphatic System Infections 1105 Chapter 25 Circulatory and Lymphatic System Infections Figure 25.1 Yellow fever is a viral hemorrhagic disease that can cause liver damage, resulting in jaundice (left) as well as serious and sometimes fatal complications. The virus that causes yellow fever is transmitted through the bite of a biological vector, the Aedes aegypti mosquito (right). (credit left: modification of work by Centers for Disease Control and Prevention; credit right: modification of work by James Gathany, Centers for Disease Control and Prevention) Chapter Outline 25.1 Anatomy of the Circulatory and Lymphatic Systems 25.2 Bacterial Infections of the Circulatory and Lymphatic Systems 25.3 Viral Infections of the Circulatory and Lymphatic Systems 25.4 Parasitic Infections of the Circulatory and Lymphatic Systems Introduction Yellow fever was once common in the southeastern US, with annual outbreaks of more than 25,000 infections in New Orleans in the mid-1800s.[1] In the early 20th century, efforts to eradicate the virus that causes yellow fever were successful thanks to vaccination programs and effective control (mainly through the insecticide dichlorodiphenyltrichloroethane [DDT]) of Aedes aegypti, the mosquito that serves as a vector. Today, the virus has been largely eradicated in North America. Elsewhere, efforts to contain yellow fever have been less successful. Despite mass vaccination campaigns in some regions, the risk for yellow fever epidemics is rising in dense urban cities in Africa and South America.[2] In an increasingly globalized society, yellow fever could easily make a comeback in North America, where A. aegypti is still present.
    [Show full text]
  • Investigation of Swabs from Skin and Superficial Soft Tissue Infections
    UK Standards for Microbiology Investigations Investigation of swabs from skin and superficial soft tissue infections Issued by the Standards Unit, Microbiology Services, PHE Bacteriology | B 11 | Issue no: 6.5 | Issue date: 19.12.18 | Page: 1 of 37 © Crown copyright 2018 Investigation of swabs from skin and superficial soft tissue infections Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the medical editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories PHE publications gateway number: 2016056 UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology | B 11 | Issue no: 6.5 | Issue date: 19.12.18 | Page: 2 of 37 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Investigation of swabs from skin and superficial soft tissue infections Contents Acknowledgments ................................................................................................................
    [Show full text]
  • Infectious Diseases of the Philippines
    INFECTIOUS DISEASES OF THE PHILIPPINES Stephen Berger, MD Infectious Diseases of the Philippines - 2013 edition Infectious Diseases of the Philippines - 2013 edition Stephen Berger, MD Copyright © 2013 by GIDEON Informatics, Inc. All rights reserved. Published by GIDEON Informatics, Inc, Los Angeles, California, USA. www.gideononline.com Cover design by GIDEON Informatics, Inc No part of this book may be reproduced or transmitted in any form or by any means without written permission from the publisher. Contact GIDEON Informatics at [email protected]. ISBN-13: 978-1-61755-582-4 ISBN-10: 1-61755-582-7 Visit http://www.gideononline.com/ebooks/ for the up to date list of GIDEON ebooks. DISCLAIMER: Publisher assumes no liability to patients with respect to the actions of physicians, health care facilities and other users, and is not responsible for any injury, death or damage resulting from the use, misuse or interpretation of information obtained through this book. Therapeutic options listed are limited to published studies and reviews. Therapy should not be undertaken without a thorough assessment of the indications, contraindications and side effects of any prospective drug or intervention. Furthermore, the data for the book are largely derived from incidence and prevalence statistics whose accuracy will vary widely for individual diseases and countries. Changes in endemicity, incidence, and drugs of choice may occur. The list of drugs, infectious diseases and even country names will vary with time. Scope of Content: Disease designations may reflect a specific pathogen (ie, Adenovirus infection), generic pathology (Pneumonia - bacterial) or etiologic grouping (Coltiviruses - Old world). Such classification reflects the clinical approach to disease allocation in the Infectious Diseases Module of the GIDEON web application.
    [Show full text]
  • Supplemental Table 1: Taxa by Symptom Taxonomy Browser Https
    Supplemental table 1: Taxa by Symptom Taxonomy Browser https://www.ncbi.nlm.nih.gov/taxonomy ↑= Enriched (X) = study number ↓= Decreased Taxa reference Phylum Class Order Family Genus Species Actinobacteria Actinobacteria Bifidobacteriales Bifidobacteriaceae Bifidobacterium Bifidobacterium infantis Actinomyces Coriobacteriia Coriobacteriales Coriobacteriaceae Eggerthella Eggerthella lenta Bacteriodetes Bacteriodia Bacteriodales Bacteroidaceae Bacteroides Bacteroides fragilis Muribaculaceae Prevotellaceae Prevotella Rikenellaceae Acetobacteroides Alistipes Rikenella Tannerellaceae Parabacteroides Porphyromonadaceae Firmicutes Bacilli Lactobacillales Lactobacillaceae Lactobacillus Enterococcaceae Enterococcus Dehalobacterium Streptococcaceae Streptococcus Streptococcus anginosus Lactococcus Clostridia Clostridiales Clostridiaceae Clostridium Clostridium histolyticum Hungatella Peptostreptococcaceae Intestinibacter Terrisporobacter Lachnospiraceae Anaerostipes Coprococcus Dorea Lachnospira Roseburia Lachnoclostridium Taxa reference Phylum Class Order Family Genus Species Tyzzerella Oscillospiraceae Oscillibacter Ruminococcaceae Faecalibacterium Ruminococcus Caproiciproducens Oscillospira Anaerotruncus Erysipelotrichia Erysipelotrichales Erysipelotrichaceae Holdemania Coprobacillus Negativicutes Acidaminococcales Acidaminococcaceae Vellionellales Vellonellaceae Veillonella Dialister Tissierellia Tissierellales Peptoniphilaceae Anaerococcus Proteobacteria Betaproteobacteria Betaproteobacteriales Burkholderiales Burkholderiaceae Sutterellaceae
    [Show full text]